全文获取类型
收费全文 | 11180篇 |
免费 | 830篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 367篇 |
妇产科学 | 315篇 |
基础医学 | 1876篇 |
口腔科学 | 139篇 |
临床医学 | 1110篇 |
内科学 | 2447篇 |
皮肤病学 | 175篇 |
神经病学 | 823篇 |
特种医学 | 322篇 |
外国民族医学 | 1篇 |
外科学 | 1566篇 |
综合类 | 87篇 |
一般理论 | 23篇 |
预防医学 | 813篇 |
眼科学 | 189篇 |
药学 | 683篇 |
中国医学 | 13篇 |
肿瘤学 | 1036篇 |
出版年
2023年 | 59篇 |
2022年 | 102篇 |
2021年 | 230篇 |
2020年 | 151篇 |
2019年 | 243篇 |
2018年 | 270篇 |
2017年 | 161篇 |
2016年 | 199篇 |
2015年 | 258篇 |
2014年 | 339篇 |
2013年 | 510篇 |
2012年 | 785篇 |
2011年 | 859篇 |
2010年 | 490篇 |
2009年 | 387篇 |
2008年 | 759篇 |
2007年 | 812篇 |
2006年 | 783篇 |
2005年 | 759篇 |
2004年 | 712篇 |
2003年 | 662篇 |
2002年 | 665篇 |
2001年 | 93篇 |
2000年 | 81篇 |
1999年 | 108篇 |
1998年 | 164篇 |
1997年 | 103篇 |
1996年 | 102篇 |
1995年 | 90篇 |
1994年 | 67篇 |
1993年 | 61篇 |
1992年 | 55篇 |
1991年 | 42篇 |
1990年 | 42篇 |
1989年 | 39篇 |
1988年 | 25篇 |
1987年 | 40篇 |
1986年 | 31篇 |
1985年 | 33篇 |
1984年 | 49篇 |
1983年 | 46篇 |
1982年 | 54篇 |
1981年 | 58篇 |
1980年 | 73篇 |
1979年 | 38篇 |
1978年 | 33篇 |
1977年 | 21篇 |
1976年 | 24篇 |
1975年 | 22篇 |
1974年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
Baujat G Rio M Rossignol S Sanlaville D Lyonnet S Le Merrer M Munnich A Gicquel C Colleaux L Cormier-Daire V 《American journal of medical genetics. Part C, Seminars in medical genetics》2005,(1):4-11
Here, we report the clinical and molecular analysis of 75 patients with overgrowth and mental retardation, including 45 previously reported cases [Rio et al., 2003; Baujat et al., 2004]. Two groups are distinguished: group I corresponding to patients with recognizable overgrowth syndromes (Sotos syndrome (SS), Weaver syndrome (WS), Beckwith-Wiedemann syndrome, Simpson-Golabi-Behmel syndrome (SGBS), and del(22)(qter) syndrome) (60 cases) and group II corresponding to unclassified cases (15 patients). We investigated NSD1 and GPC3 deletions or mutations, 11p15 abnormalities, and 22qter deletions. Surprisingly, in Group I, two SS patients had 11p15 abnormalities and two patients with Beckwith-Wiedemann syndrome had NSD1 aberrations. In group II, two cases of del(22)(qter) were identified but neither NSD1, 11p15, nor GPC3 abnormalities were detected. These results emphasize the clinical and molecular overlap in overgrowth conditions. 相似文献
63.
Ray V. Haning Ian H. Carlson Enid F. Gilbert Sander S. Shapiro John M. Opitz Laurence E. Karp 《American journal of medical genetics. Part A》1980,7(3):279-292
The second case of virilism as a late manifestation of Bardet-Biedl syndrome (BBS) is described, with endocrine and histological evaluation. Both cases manifested ovulatory cycles and developed virilism in adulthood. Elevated plasma testosterone and 17-OH-progesterone were not suppressed by dexamethasone but were suppressed by medroxyprogesterone acetate. Peripheral and ovarian venous blood obtained at the time of surgery demonstrated a marked gradient for testosterone in both ovaries and for progesterone in the ovary bearing the corpus luteum. Histological evaluation of the ovaries demonstrated bilateral ovarian stromal hyperplasia with focal hyperthecosis. Bilateral ovariectomy resulted in complete correction of the endocrine abnormality, although the established hirsutism remains a mark of previous androgen excess. 相似文献
64.
65.
66.
67.
The alloimmune response can be divided into specific junctures where critical decisions between tolerance and immunity are made which define the outcome of the transplant. At these "decision nodes" various cytokines direct alloresponsive T cells to develop either a proinflammatory response aimed at graft destruction or an immunoregulatory response facilitating graft acceptance. This review will focus on the role of these cytokines in influencing the progression of an alloimmune response leading ultimately to either allograft survival or rejection. 相似文献
68.
Van Melderen L 《International journal of medical microbiology : IJMM》2002,291(6-7):537-544
The ccd poison/antidote system of the F plasmid encodes CcdB, a toxin targeting the essential DNA gyrase of E. coli, and CcdA, the unstable antidote that interacts with CcdB to neutralise its toxicity. Gyrase belongs to the topoisomerase II class of enzymes and is a well-validated target for efficient therapeutic drugs, i. e. the quinolones. CcdB acts on gyrase in a similar way as quinolones do, both compounds induce double-strand breaks in DNA. Interestingly, the CcdB-binding domain of gyrase is different than that of quinolones. Therefore, novel classes of therapeutic drugs could be derived from the analysis of the interaction between CcdB and gyrase. 相似文献
69.
70.